查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區 dPCR 和 qPCR 市場預測至 2030 年 - 區域分析 - 按治療、產品、應用和最終用戶
市場調查報告書
商品編碼
1494309

亞太地區 dPCR 和 qPCR 市場預測至 2030 年 - 區域分析 - 按治療、產品、應用和最終用戶

Asia Pacific dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 105 Pages | 訂單完成後即時交付

價格

2022年亞太地區dPCR和qPCR市值為19.1343億美元，預計2030年將達到41.395億美元；預計2022年至2030年複合年成長率為10.1%。

PCR 技術的進步推動亞太地區 dPCR 和 qPCR 市場

聚合酶鍊式反應(PCR) 是一種幾乎無所不在、強大且可靠的技術，大多數分子生物學實驗室都使用它來擴增特定的DNA 片段，以進行基因分型、克隆和單核苷酸變異分析，甚至可以作為大多數下一代技術的基礎定序（NGS）準備。技術進步催生了不同類型的 PCR 技術。 PCR 技術的使用現已探索到多種非常規應用，使分子診斷變得更容易、更快捷。特別是，數位和即時 PCR 的進步可用於診斷疾病、識別病毒和細菌以及協助法醫調查。此外，研究人員正在嘗試使用一些奈米材料來減少測試時間。 2023 年 3 月，韓國科學技術院智慧感測增強安全系統中心（KIST，院長：Seok Jin Yoon）宣布，Sang Kyung Kim 博士（主任）和鄭勝元的研究團隊。與先前利用光熱奈米材料進行的測試相比，超快速PCR將測試時間縮短了十倍。新方法的診斷效能與目前的測試方法相當，並且可以在5分鐘內完成。因此，PCR 技術的進步推動了亞太地區 dPCR 和 qPCR 市場的成長。

亞太地區 dPCR 和 qPCR 市場概覽

亞太地區的 dPCR 和 qPCR 市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。中國、印度和日本是市場成長的三個主要貢獻者，這些國家的外國直接投資不斷增加，高技能、高效和大量的勞動力，以及精簡的政府政策導致生物技術領域的高投資。此外，傳染病和慢性病病例的增加以及政府和非政府措施也推動了亞太地區 dPCR 和 qPCR 市場的成長。

亞太地區 dPCR 和 qPCR 市場收入及 2030 年預測（百萬美元）

亞太地區 dPCR 和 qPCR 市場細分

亞太地區 dPCR 和 qPCR 市場根據治療、產品、應用、最終用戶和國家進行細分。

根據處理方式，亞太地區 dPCR 和 qPCR 市場分為定量 PCR (qPCR) 和數位 PCR (dPCR)。到 2022 年，數位 PCR (dPCR) 領域將佔據更大的佔有率。

依產品分類，亞太地區 dPCR 和 qPCR 市場分為試劑和耗材、儀器以及軟體和服務。 2022 年，試劑和耗材領域佔最大佔有率。

依應用分類，亞太地區 dPCR 和 qPCR 市場分為研究應用、臨床應用和法醫應用。 2022年，臨床應用領域佔據最大佔有率。

按最終用戶分類，亞太地區 dPCR 和 qPCR 市場分為醫院和診斷中心、製藥和生物技術公司、研究實驗室和學術機構、法醫實驗室以及臨床研究組織。 2022 年，醫院和診斷中心細分市場佔據最大佔有率。

依國家/地區分類，亞太地區 dPCR 和 qPCR 市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022 年，中國在亞太地區 dPCR 和 qPCR 市場佔據主導地位。

Abbott Laboratories、Thermo Fisher Scientific Inc、Takara Bio Inc、Genome Diagnostics Pvt Ltd、Qiagen NV、Standard BioTools Inc、樂普醫療科技北京有限公司、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc 和 Agilent Technologies Inc.一些在亞太地區dPCR 和qPCR 市場營運的領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區 dPCR 和 qPCR 市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病和傳染病的發生率增加
    • 基因合成的投資和資金不斷增加
    • PCR 技術的技術進步
  • 市場限制
    • PCR 系統成本高
    • 與 qPCR 相關的技術限制
  • 市場機會
    • 新興國家擴大採用 PCR 方法
  • 未來的趨勢
    • 微滴式數位PCR的發展
  • 影響分析：

第 5 章：dPCR 和 qPCR 市場 - 亞太市場分析

  • 亞太地區 dPCR 和 qPCR 市場收入，2022 - 2030

第 6 章：亞太地區 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按治療方式

  • 概述
  • 2022 年和 2030 年亞太地區 dPCR 和 qPCR 市場收入佔有率（按治療方式）（%）
  • 定量PCR
  • 數位PCR

第 7 章：亞太地區 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年亞太地區 dPCR 和 qPCR 市場收入佔有率（按產品）（%）
  • 試劑及耗材
  • 儀器
  • 軟體與服務

第 8 章：亞太地區 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按應用

  • 概述
  • 2022 年和 2030 年亞太地區 dPCR 和 qPCR 市場收入佔有率（按應用）（%）
  • 研究應用
  • 臨床應用
  • 法醫應用

第 9 章：亞太地區 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年亞太地區 dPCR 和 qPCR 市場收入佔有率（按最終用戶）（%）
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究實驗室和學術機構
  • 法醫實驗室
  • 臨床研究組織

第 10 章：亞太地區 dPCR 和 qPCR 市場 - 國家分析

    • 亞太地區 dPCR 和 qPCR 市場（依國家）
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 亞太地區其他地區

第 11 章：dPCR 與 qPCR 市場產業模式

  • 概述
  • 亞太地區 dPCR 和 qPCR 市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • Genome Diagnostics Pvt Ltd

第 13 章：附錄

Product Code: BMIRE00029880

The Asia Pacific dPCR and qPCR market was valued at US$ 1,913.43 million in 2022 and is expected to reach US$ 4,139.50 million by 2030; it is estimated to grow at a CAGR of 10.1% from 2022 to 2030.

Technological Advancements in PCR Technologies Drive Asia Pacific dPCR and qPCR Market

Polymerase chain reaction (PCR) is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations and even serves as the basis for most next-generation sequencing (NGS) preparation. Technological advances are yielding different types of PCR techniques. The use of PCR technology has now been explored into several non-conventional applications, making molecular diagnosis easier and faster. In particular, advances in digital and real-time PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Moreover, the researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST, President: Seok Jin Yoon) announced the development of an ultrafast PCR technology by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by ten times compared to the previous test by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to the current test method, and it can be finished in 5 minutes. Thus, technological advancements in PCR technologies propel the Asia Pacific dPCR and qPCR market growth.

Asia Pacific dPCR and qPCR Market Overview

The Asia Pacific dPCR and qPCR market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China, India and Japan are three major contributors to the growth of the market which is driven by increasing foreign direct investments in these countries, highly skilled, efficient and large number of labor, and streamlining government policies resulting in high investments for biotechnology sector. In addition, increasing cases of infectious and chronic diseases and government and non-government initiatives are also responsible for fueling the growth of the Asia Pacific dPCR and qPCR market.

Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific dPCR and qPCR Market Segmentation

The Asia Pacific dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Asia Pacific dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Asia Pacific dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Asia Pacific dPCR and qPCR market is research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Asia Pacific dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Asia Pacific dPCR and qPCR market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Genome Diagnostics Pvt Ltd, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Asia Pacific dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific dPCR and qPCR Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 4.1.2 Rising Investments and Funds for Gene Synthesis
    • 4.1.3 Technological Advancements in PCR Technologies
  • 4.2 Market Restraints
    • 4.2.1 High Costs of PCR Systems
    • 4.2.2 Technical Limitations Associated with qPCR
  • 4.3 Market Opportunities
    • 4.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 4.4 Future Trends
    • 4.4.1 Development of Droplet Digital PCR
  • 4.5 Impact Analysis:

5. dPCR and qPCR Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 6.1 Overview
  • 6.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 6.3 Quantitative PCR
    • 6.3.1 Overview
    • 6.3.2 Quantitative PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Digital PCR
    • 6.4.1 Overview
    • 6.4.2 Digital PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 7.3 Reagents & Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents & Consumables: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Software & Services
    • 7.5.1 Overview
    • 7.5.2 Software & Services: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 8.3 Research Application
    • 8.3.1 Overview
    • 8.3.2 Research Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinical Application
    • 8.4.1 Overview
    • 8.4.2 Clinical Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 Asia Pacific dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 8.5 Forensic Application
    • 8.5.1 Overview
    • 8.5.2 Forensic Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Research Laboratories and Academic Institutes
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Forensic Laboratories
    • 9.6.1 Overview
    • 9.6.2 Forensic Laboratories: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Clinical Research Organizations
    • 9.7.1 Overview
    • 9.7.2 Clinical Research Organizations: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific dPCR and qPCR Market - Country Analysis

    • 10.1.1 Asia Pacific dPCR and qPCR Market, by Country
      • 10.1.1.1 China
        • 10.1.1.1.1 China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 China: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.1.3 China: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.4 China: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.4.1 China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.1.5 China: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.2 Japan
        • 10.1.1.2.1 Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Japan: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Japan: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Japan: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4.1 Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.2.5 Japan: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.3 India
        • 10.1.1.3.1 India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 India: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.3.3 India: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.4 India: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4.1 India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.3.5 India: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.4 Australia
        • 10.1.1.4.1 Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Australia: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Australia: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Australia: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.4.4.1 Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.4.5 Australia: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.5 South Korea
        • 10.1.1.5.1 South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.2 South Korea: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.5.3 South Korea: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.5.4 South Korea: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.5.4.1 South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.5.5 South Korea: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific
        • 10.1.1.6.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11. dPCR and qPCR Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Asia Pacific dPCR and qPCR Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Takara Bio Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Qiagen NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Standard BioTools Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lepu Medical Technology Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 F. Hoffmann-La Roche Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Agilent Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Genome Diagnostics Pvt Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific dPCR and qPCR Market Segmentation
  • Table 2. Asia Pacific dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. China: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Japan: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. India: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. India: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. India: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. India: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Australia: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Australia: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Australia: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Australia: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. South Korea: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. South Korea: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. South Korea: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. South Korea: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Recent Organic Growth Strategies in Asia Pacific dPCR and qPCR Market
  • Table 34. Recent Inorganic Growth Strategies in the Asia Pacific dPCR and qPCR Market
  • Table 35. Glossary of Terms, Asia Pacific dPCR and qPCR Market

List Of Figures

  • Figure 1. Asia Pacific dPCR and qPCR Market Segmentation, By Country
  • Figure 2. Asia Pacific dPCR and qPCR Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 6. Quantitative PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Digital PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 9. Reagents & Consumables: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Instruments: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Software & Services: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 13. Research Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Clinical Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Forensic Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 17. Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Forensic Laboratories: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Clinical Research Organizations: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Asia Pacific dPCR and qPCR Market